Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

BioLineRx Ltd. (BLRX) had Revenue of $0.26M for the most recently reported fiscal quarter, ending 2025-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-03-31

Income Statement Financials
Revenue	$0.26M
Net Income	$5.13M
Cost of Goods Sold	$0.03M
Gross Profit	$0.22M
Operating Expenses	$2.65M
Operating Income	$-2.39M
Non-Operating Income/Expense	$7.52M
Pre-Tax Income	$5.13M
Normalized Pre-Tax Income	$5.13M
Income after Taxes	$5.13M
Income from Continuous Operations	$5.13M
Consolidated Net Income/Loss	$5.13M
Normalized Income after Taxes	$5.13M
EBIT	$-2.39M
EBITDA	$-2.23M
Weighted-Average Shares Outstanding (Basic)	3.70M
Weighted-Average Shares Outstanding (Diluted)	3.70M
Earnings per Share (EPS) (Basic)	$0.00
Earnings per Share (EPS) (Diluted)	$0.00
Balance Sheet Financials
Current Assets	$31.92M
Property, Plant, and Equipment	$0.30M
Long-Term Assets	$11.59M
Total Assets	$43.51M
Current Liabilities	$14.03M
Long-Term Debt	$7.63M
Long-Term Liabilities	$8.62M
Total Liabilities	$22.65M
Common Equity	$20.86M
Tangible Shareholders Equity	$10.43M
Shareholders Equity	$20.86M
Common Shares Outstanding	3.72M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-2.59M
Cash Flow from Investing Activities	$-8.18M
Cash Flow from Financial Activities	$9.45M
Beginning Cash	$10.44M
End Cash	$9.04M
Increase/Decrease in Cash	$-1.40M
Stock-Based Compensation	$0.19M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.27
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.27
Debt to Equity Ratio	0.59
Gross Margin	86.67%
Operating Margin	-937.65%
EBIT Margin	-937.65%
EBITDA Margin	--
Pre-Tax Profit Margin	2010.59%
Profit Margin	2010.59%
Free Cash Flow	$-2.59M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.01
Inventory Turnover	0.01
Receiveable Turnover	0.13
Days Sales in Receivables	678.00
Return on Equity	24.58%
Return on Tangible Equity	49.15%
Return on Assets	11.78%
Return on Investments	17.99%
Book Value Per Share	$5.61
Free Cash Flow per Share	$-0.70
Operating Cash Flow per Share	$-0.70

Data from Zacks Investment Research, Inc.